Refine
Year of publication
Document Type
- Article (44)
- Part of Periodical (2)
Has Fulltext
- yes (46)
Is part of the Bibliography
- no (46)
Keywords
- Herb induced liver injury (4)
- Magnetic resonance imaging (3)
- Algorithms (2)
- Bone density (2)
- Cancer (2)
- Causality assessment (2)
- Drug hepatotoxicity (2)
- Drug induced liver injury (2)
- Hepatocellular carcinoma (2)
- Herbal hepatotoxicity (2)
- Multidetector computed tomography (2)
- Osteoporosis (2)
- Pelargonium sidoides (2)
- Spine (2)
- Tomography (x-ray computed) (2)
- 19F (1)
- Adelgidae (1)
- Age determination by skeleton (1)
- Aphids (1)
- Applied vegetation science (1)
- Artificial intelligence (1)
- Attention-Deficit/Hyperactivity Disorder (ADHD) (1)
- Biomarkers (1)
- Bone diseases, Metabolic (1)
- Bone marrow (1)
- Brain tumor (1)
- Breast tumors (1)
- Bryophyta (1)
- CAC-DRS Score (1)
- CEND-1 (1)
- CIOMS (1)
- COVID-19 (1)
- CT dual-energy computed tomography (1)
- Calcium (1)
- Cancer genetics (1)
- Cancer genomics (1)
- Cell binding (1)
- Cell staining (1)
- Centers for Disease Control and Prevention (1)
- Cerebral toxoplasmosis HIV (1)
- Cinarinae (1)
- Climate-change ecology (1)
- Cohort studies (1)
- Community ecology (1)
- Computed Tomography (1)
- Computed tomography (1)
- Computed tomography, X-ray (1)
- Contingent Negative Variation, CNV (1)
- Continuous Performance Test, CPT (1)
- Contrast agent (1)
- Coronary Heart Disease (1)
- Coronary Plaque Burden (1)
- Council for International Organizations of Medical Sciences (1)
- Cue-P3 (1)
- CyberKnife robotic radiosurgery (1)
- DNA-PAINT (1)
- DSM (1)
- Delivery quality assurance (1)
- Diagnosis (1)
- Diagnostic accuracy (1)
- Diagnostic imaging (1)
- Drugs (1)
- Dry Grassland Working Group (1)
- Dual-energy computed tomography (1)
- Ecological modelling (1)
- Ecological networks (1)
- Edema (1)
- Endovascular aortic repair (1)
- Event related potentials (1)
- FBS (1)
- Festuco-Brometea (1)
- Flow cytometry (1)
- Food and Drug Administration (1)
- Gastrointestinal (1)
- Genetics (1)
- Genome-wide association studies (1)
- Genomic instability (1)
- Glioma (1)
- Hawaii Department of Health (1)
- Heart transplantation (1)
- Herbalife products (1)
- Herbs (1)
- Herniated disk (1)
- Honolulu Queen’s Medical Center (1)
- Image processing (1)
- Image processing (computer-assisted) (1)
- Immunology (1)
- Intervertebral disc displacement (1)
- Kava (1)
- Ki67 transgenic c‐myc/TGFα mice (1)
- Koelerio-Corynephoretea (1)
- Kupffer cells (1)
- LSTA1 (1)
- Late presentation (1)
- Lipiodol (1)
- Liquid filled MicroLion ion chamber array (1)
- Macrophages (1)
- Medical Physics: Diagnostic (1)
- Mitomycin C (1)
- Molecular diagnostic testing (1)
- Molecular matched therapy (1)
- Molecular medicine (1)
- Molecular profiling (1)
- Mouse models (1)
- Necrotic area (1)
- Neurofeedback (1)
- Non-small cell lung cancer (1)
- Nordic aphids on conifers (1)
- Opportunistic infections (1)
- Osteoporotic fractures (1)
- OxyELITE Pro (1)
- PCP (1)
- Pelargonium sidoides questionable hepatotoxicity (1)
- Phantoms (imaging) (1)
- Pharmacovigilance (1)
- Pneumocystis jirovecii (1)
- Positron emission tomography (1)
- Pteridophyta (1)
- RNA (1)
- Radiology (1)
- Randomized Controlled Trial (1)
- Re-exposure (1)
- Registries (1)
- Response (1)
- Response control (1)
- Retrospective studies (1)
- Retrospective study (1)
- SARS-CoV-2 (1)
- SARS-CoV-2 Pneumonia (1)
- Slow Cortical Potentials, SCP (1)
- Spinal fractures (1)
- Stereotactic body radiation therapy (1)
- Survival (1)
- Sustained attention (1)
- TACE (1)
- Targeted therapy (1)
- Thoracic aortic aneurysm (1)
- Thorax (1)
- Tomography (1)
- Treatment (1)
- Tumor volume (1)
- Vasculitis (1)
- Viral infection (1)
- Virtual noncalcium reconstructions (1)
- Workstation comparison (1)
- X-ray computed (1)
- angiography (1)
- certepetide (1)
- cholangiocarcinoma (1)
- clock genes (1)
- colour images (1)
- computer-assisted (1)
- conference report (1)
- diagnostic imaging (1)
- endoscopic retrograde cholangiopancreatography (1)
- fimaporfin (1)
- fluorine (1)
- fragment-based screening (1)
- gemcitabine (1)
- hepatocellular carcinoma (1)
- iRGD peptide (1)
- identification (1)
- identification keys (1)
- in vivo dosimetry (1)
- liver (1)
- multidetector computed tomography (1)
- pharmacokinetics (1)
- photochemical internalization (1)
- photographs (1)
- portal vein (1)
- proteins (1)
- quantitative radioactivity analysis (QRA) (1)
- quantitative whole-body autoradiography (QWBA) (1)
- radiation dosage (1)
- radiation dosimetry (1)
- radiation protection (1)
- restoration ecology (1)
- thrombosis (1)
- γ‐H2AX (1)
Institute
- Medizin (39)
- Biochemie, Chemie und Pharmazie (1)
- Biodiversität und Klima Forschungszentrum (BiK-F) (1)
- Biowissenschaften (1)
- Geographie (1)
- Institut für Ökologie, Evolution und Diversität (1)
- Physik (1)
- Sonderforschungsbereiche / Forschungskollegs (1)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (1)
From sea to land and beyond : new insights into the evolution of euthyneuran Gastropoda (Mollusca)
(2008)
Background The Euthyneura are considered to be the most successful and diverse group of Gastropoda. Phylogenetically, they are riven with controversy. Previous morphology-based phylogenetic studies have been greatly hampered by rampant parallelism in morphological characters or by incomplete taxon sampling. Based on sequences of nuclear 18S rRNA and 28S rRNA as well as mitochondrial 16S rRNA and COI DNA from 56 taxa, we reconstructed the phylogeny of Euthyneura utilising Maximum Likelihood and Bayesian inference methods. The evolution of colonization of freshwater and terrestrial habitats by pulmonate Euthyneura, considered crucial in the evolution of this group of Gastropoda, is reconstructed with Bayesian approaches. Results We found several well supported clades within Euthyneura, however, we could not confirm the traditional classification, since Pulmonata are paraphyletic and Opistobranchia are either polyphyletic or paraphyletic with several clades clearly distinguishable. Sacoglossa appear separately from the rest of the Opisthobranchia as sister taxon to basal Pulmonata. Within Pulmonata, Basommatophora are paraphyletic and Hygrophila and Eupulmonata form monophyletic clades. Pyramidelloidea are placed within Euthyneura rendering the Euthyneura paraphyletic. Conclusion Based on the current phylogeny, it can be proposed for the first time that invasion of freshwater by Pulmonata is a unique evolutionary event and has taken place directly from the marine environment via an aquatic pathway. The origin of colonisation of terrestrial habitats is seeded in marginal zones and has probably occurred via estuaries or semi-terrestrial habitats such as mangroves.
We report here the nuclear magnetic resonance 19F screening of 14 RNA targets with different secondary and tertiary structure to systematically assess the druggability of RNAs. Our RNA targets include representative bacterial riboswitches that naturally bind with nanomolar affinity and high specificity to cellular metabolites of low molecular weight. Based on counter-screens against five DNAs and five proteins, we can show that RNA can be specifically targeted. To demonstrate the quality of the initial fragment library that has been designed for easy follow-up chemistry, we further show how to increase binding affinity from an initial fragment hit by chemistry that links the identified fragment to the intercalator acridine. Thus, we achieve low-micromolar binding affinity without losing binding specificity between two different terminator structures.
Purpose: Molecular diagnostics including next generation gene sequencing are increasingly used to determine options for individualized therapies in brain tumor patients. We aimed to evaluate the decision-making process of molecular targeted therapies and analyze data on tolerability as well as signals for efficacy.
Methods: Via retrospective analysis, we identified primary brain tumor patients who were treated off-label with a targeted therapy at the University Hospital Frankfurt, Goethe University. We analyzed which types of molecular alterations were utilized to guide molecular off-label therapies and the diagnostic procedures for their assessment during the period from 2008 to 2021. Data on tolerability and outcomes were collected.
Results: 413 off-label therapies were identified with an increasing annual number for the interval after 2016. 37 interventions (9%) were targeted therapies based on molecular markers. Glioma and meningioma were the most frequent entities treated with molecular matched targeted therapies. Rare entities comprised e.g. medulloblastoma and papillary craniopharyngeoma. Molecular targeted approaches included checkpoint inhibitors, inhibitors of mTOR, FGFR, ALK, MET, ROS1, PIK3CA, CDK4/6, BRAF/MEK and PARP. Responses in the first follow-up MRI were partial response (13.5%), stable disease (29.7%) and progressive disease (46.0%). There were no new safety signals. Adverse events with fatal outcome (CTCAE grade 5) were not observed. Only, two patients discontinued treatment due to side effects. Median progression-free and overall survival were 9.1/18 months in patients with at least stable disease, and 1.8/3.6 months in those with progressive disease at the first follow-up MRI.
Conclusion: A broad range of actionable alterations was targeted with available molecular therapeutics.
However, efficacy was largely observed in entities with paradigmatic oncogenic drivers, in particular with BRAF mutations. Further research on biomarker-informed molecular matched therapies is urgently necessary.
This paper reports on Monte Carlo simulation results for future measurements of the moduli of time-like proton electromagnetic form factors, |GE | and |GM|, using the ¯pp → μ+μ− reaction at PANDA (FAIR). The electromagnetic form factors are fundamental quantities parameterizing the electric and magnetic structure of hadrons. This work estimates the statistical and total accuracy with which the form factors can be measured at PANDA, using an analysis of simulated data within the PandaRoot software framework. The most crucial background channel is ¯pp → π+π−,due to the very similar behavior of muons and pions in the detector. The suppression factors are evaluated for this and all other relevant background channels at different values of antiproton beam momentum. The signal/background separation is based on a multivariate analysis, using the Boosted Decision Trees method. An expected background subtraction is included in this study, based on realistic angular distribuations of the background contribution. Systematic uncertainties are considered and the relative total uncertainties of the form factor measurements are presented.
Chordomas are rare bone tumors with few therapeutic options. Here we show, using whole-exome and genome sequencing within a precision oncology program, that advanced chordomas (n = 11) may be characterized by genomic patterns indicative of defective homologous recombination (HR) DNA repair and alterations affecting HR-related genes, including, for example, deletions and pathogenic germline variants of BRCA2, NBN, and CHEK2. A mutational signature associated with HR deficiency was significantly enriched in 72.7% of samples and co-occurred with genomic instability. The poly(ADP-ribose) polymerase (PARP) inhibitor olaparib, which is preferentially toxic to HR-incompetent cells, led to prolonged clinical benefit in a patient with refractory chordoma, and whole-genome analysis at progression revealed a PARP1 p.T910A mutation predicted to disrupt the autoinhibitory PARP1 helical domain. These findings uncover a therapeutic opportunity in chordoma that warrants further exploration, and provide insight into the mechanisms underlying PARP inhibitor resistance.
Dual-energy CT (DECT) has emerged into clinical routine as an imaging technique with unique postprocessing utilities that improve the evaluation of different body areas. The virtual non-calcium (VNCa) reconstruction algorithm has shown beneficial effects on the depiction of bone marrow pathologies such as bone marrow edema. Its main advantage is the ability to substantially increase the image contrast of structures that are usually covered with calcium mineral, such as calcified vessels or bone marrow, and to depict a large number of traumatic, inflammatory, infiltrative, and degenerative disorders affecting either the spine or the appendicular skeleton. Therefore, VNCa imaging represents another step forward for DECT to image conditions and disorders that usually require the use of more expensive and time-consuming techniques such as magnetic resonance imaging, positron emission tomography/CT, or bone scintigraphy. The aim of this review article is to explain the technical background of VNCa imaging, showcase its applicability in the different body regions, and provide an updated outlook on the clinical impact of this technique, which goes beyond the sole improvement in image quality.
Objectives: To determine the diagnostic accuracy of dual-energy CT (DECT) virtual noncalcium (VNCa) reconstructions for assessing thoracic disk herniation compared to standard grayscale CT. Methods: In this retrospective study, 87 patients (1131 intervertebral disks; mean age, 66 years; 47 women) who underwent third-generation dual-source DECT and 3.0-T MRI within 3 weeks between November 2016 and April 2020 were included. Five blinded radiologists analyzed standard DECT and color-coded VNCa images after a time interval of 8 weeks for the presence and degree of thoracic disk herniation and spinal nerve root impingement. Consensus reading of independently evaluated MRI series served as the reference standard, assessed by two separate experienced readers. Additionally, image ratings were carried out by using 5-point Likert scales. Results: MRI revealed a total of 133 herniated thoracic disks. Color-coded VNCa images yielded higher overall sensitivity (624/665 [94%; 95% CI, 0.89–0.96] vs 485/665 [73%; 95% CI, 0.67–0.80]), specificity (4775/4990 [96%; 95% CI, 0.90–0.98] vs 4066/4990 [82%; 95% CI, 0.79–0.84]), and accuracy (5399/5655 [96%; 95% CI, 0.93–0.98] vs 4551/5655 [81%; 95% CI, 0.74–0.86]) for the assessment of thoracic disk herniation compared to standard CT (all p < .001). Interrater agreement was excellent for VNCa and fair for standard CT (ϰ = 0.82 vs 0.37; p < .001). In addition, VNCa imaging achieved higher scores regarding diagnostic confidence, image quality, and noise compared to standard CT (all p < .001). Conclusions: Color-coded VNCa imaging yielded substantially higher diagnostic accuracy and confidence for assessing thoracic disk herniation compared to standard CT.
Background: Dual-source dual-energy computed tomography (DECT) offers the potential for opportunistic osteoporosis screening by enabling phantomless bone mineral density (BMD) quantification. This study sought to assess the accuracy and precision of volumetric BMD measurement using dual-source DECT in comparison to quantitative CT (QCT). Methods: A validated spine phantom consisting of three lumbar vertebra equivalents with 50 (L1), 100 (L2), and 200 mg/cm3 (L3) calcium hydroxyapatite (HA) concentrations was scanned employing third-generation dual-source DECT and QCT. While BMD assessment based on QCT required an additional standardised bone density calibration phantom, the DECT technique operated by using a dedicated postprocessing software based on material decomposition without requiring calibration phantoms. Accuracy and precision of both modalities were compared by calculating measurement errors. In addition, correlation and agreement analyses were performed using Pearson correlation, linear regression, and Bland-Altman plots. Results: DECT-derived BMD values differed significantly from those obtained by QCT (p < 0.001) and were found to be closer to true HA concentrations. Relative measurement errors were significantly smaller for DECT in comparison to QCT (L1, 0.94% versus 9.68%; L2, 0.28% versus 5.74%; L3, 0.24% versus 3.67%, respectively). DECT demonstrated better BMD measurement repeatability compared to QCT (coefficient of variance < 4.29% for DECT, < 6.74% for QCT). Both methods correlated well to each other (r = 0.9993; 95% confidence interval 0.9984–0.9997; p < 0.001) and revealed substantial agreement in Bland-Altman plots. Conclusions: Phantomless dual-source DECT-based BMD assessment of lumbar vertebra equivalents using material decomposition showed higher diagnostic accuracy compared to QCT.
Objectives: To compare dual-energy CT (DECT) and MRI for assessing presence and extent of traumatic bone marrow edema (BME) and fracture line depiction in acute vertebral fractures. Methods: Eighty-eight consecutive patients who underwent dual-source DECT and 3-T MRI of the spine were retrospectively analyzed. Five radiologists assessed all vertebrae for presence and extent of BME and for identification of acute fracture lines on MRI and, after 12 weeks, on DECT series. Additionally, image quality, image noise, and diagnostic confidence for overall diagnosis of acute vertebral fracture were assessed. Quantitative analysis of CT numbers was performed by a sixth radiologist. Two radiologists analyzed MRI and grayscale DECT series to define the reference standard. Results: For assessing BME presence and extent, DECT showed high sensitivity (89% and 84%, respectively) and specificity (98% in both), and similarly high diagnostic confidence compared to MRI (2.30 vs. 2.32; range 0–3) for the detection of BME (p = .72). For evaluating acute fracture lines, MRI achieved high specificity (95%), moderate sensitivity (76%), and a significantly lower diagnostic confidence compared to DECT (2.42 vs. 2.62, range 0–3) (p < .001). A cutoff value of − 0.43 HU provided a sensitivity of 89% and a specificity of 90% for diagnosing BME, with an overall AUC of 0.96. Conclusions: DECT and MRI provide high diagnostic confidence and image quality for assessing acute vertebral fractures. While DECT achieved high overall diagnostic accuracy in the analysis of BME presence and extent, MRI provided moderate sensitivity and lower confidence for evaluating fracture lines.
Background: To evaluate clinical outcomes after either immediate or deferred initiation of antiretroviral therapy in HIV-1-infected patients, presenting late with pneumocystis pneumonia (PCP) or toxoplasma encephalitis (TE).
Methods: Phase IV, multicenter, prospective, randomized open-label clinical trial. Patients were randomized into an immediate therapy arm (starting antiretroviral therapy (ART) within 7 days after initiation of OI treatment) versus a deferred arm (starting ART after completing the OI-therapy). All patients were followed for 24 weeks. The rates of clinical progression (death, new or relapsing opportunistic infections (OI) and other grade 4 clinical endpoints) were compared, using a combined primary endpoint. Secondary endpoints were hospitalization rates after completion of OI treatment, incidence of immune reconstitution inflammatory syndrome (IRIS), virologic and immunological outcome, adherence to proteinase-inhibitor based antiretroviral therapy (ART) protocol and quality of life.
Results: 61 patients (11 patients suffering TE, 50 with PCP) were enrolled. No differences between the two therapy groups in all examined primary and secondary endpoints could be identified: immunological and virologic outcome was similar in both groups, there was no significant difference in the incidence of IRIS (11 and 10 cases), furthermore 9 events (combined endpoint of death, new/relapsing OI and grade 4 events) occurred in each group.
Conclusions: In summary, this study supports the notion that immediate initiation of ART with a ritonavir-boosted proteinase-inhibitor and two nucleoside reverse transcriptase inhibitors is safe and has no negative effects on incidence of disease progression or IRIS, nor on immunological and virologic outcomes or on quality of life.